Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T76701
(Former ID: TTDI01543)
|
|||||
Target Name |
Cyclin D1/E2F pathway (CCND1/E2F pathway)
|
|||||
Synonyms |
Cyclin D1/E2F pathway signalling
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Discontinued target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Qualitative platelet defect [ICD-11: 3B62] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Discontinued Drug(s) | [+] 1 Discontinued Drugs | + | ||||
1 | Trombodipine | Drug Info | Discontinued in Phase 2 | Platelet aggregation disorder | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Trombodipine | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation. Br J Pharmacol. 2001 April; 132(7): 1597-1605. | |||||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000277) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.